Cagrilintide-semaglutide plus basal insulin lowered A1C and weight in adults with type 2 diabetes
A Lancet phase 3a trial found cagrilintide-semaglutide added to basal insulin lowered A1C and weight...
Berobenatide VESPER Results: What Patients Should Know
Phase 2b VESPER data suggest berobenatide may lower weight and A1C, but it remains investigational...
Awiqli Once-Weekly Basal Insulin: What Adults With Type 2 Diabetes Should Know
Awiqli is FDA-approved as a once-weekly basal insulin for adults with type 2 diabetes. Learn...
Automated Insulin Delivery and Advanced Kidney Disease: What People With Diabetes Should Know
A randomized trial found that automated insulin delivery improved time in range for adults with...
Afrezza Inhaled Insulin for Children: What Families Should Check
Patient-friendly Afrezza pediatric approval update covering age, mealtime insulin role, lung safety, hypoglycemia, DKA limits...